Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
ALK positive NSCLC patients
.
Show all posts
Showing posts with label
ALK positive NSCLC patients
.
Show all posts
Wednesday, December 27, 2017
Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients
›
In continuation of my update on crizotinib and alectinib and A subanalysis of the phase III ALEX study has shown that alectinib 60...
›
Home
View web version
